Nalaganje...
Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy
Inhibiting the programmed cell death ligand-1 (PD-L1)/programmed cell death receptor-1 (PD-1) signaling axis reinvigorates the antitumor immune response with remarkable clinical efficacy. Yet, low response rates limit the benefits of immunotherapy to a minority of patients. Recent studies have explo...
Shranjeno v:
| izdano v: | J Immunol Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7886511/ https://ncbi.nlm.nih.gov/pubmed/33628854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/8839978 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|